Endothelial cell sphingosine 1-phosphate receptor 1 restrains VE-cadherin cleavage and attenuates experimental inflammatory arthritis
Nathalie Burg(Hospital for Special Surgery), Jane E. Salmon(Hospital for Special Surgery), Dietmar Vestweber(Max Planck Institute for Molecular Biomedicine), Linda Alex(Albert Einstein College of Medicine), Carl Blobel(Hospital for Special Surgery), Bella Mehta(Hospital for Special Surgery), Susan M. Goodman(Hospital for Special Surgery), Tilla S. Worgall(Columbia University Irving Medical Center), Andrew Kuo(Boston Children's Hospital), Kevin Wei(Brigham and Women's Hospital), Kalana S. Athukorala(University of Michigan), Heather J. Faust(Brigham and Women's Hospital), Margaret Minett(Hospital for Special Surgery), Ryan Malpass(Hospital for Special Surgery), Eric Englebrecht(University of Louisville), Tania Pannelini(Hospital for Special Surgery), Michael Brenner(Michigan Medicine), Miles Tran(Brigham and Women's Hospital), Timothy Hla(Boston Children's Hospital)
Cited by 11
Related Papers
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
|Pharmacological Reviews|2004|1.7k
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
Sequential contribution of L- and P-selectin to leukocyte rolling in vivo.
|The Journal of Experimental Medicine|1995|585
An update on the biology of sphingosine 1-phosphate receptors
|Journal of Lipid Research|2014|514